If you can still read this message after the webpage has finished loading, then your browser may not be capable of using CSS to display this site correctly. Please view the website information page for further details.
Abstract submission deadline
21 October 2011
End of earlybird registration deadline:
21 October 2011
Guaranteed Hotel Reservation Deadline:
02 December 2011
Registrations must be made onsite after:
26 January 2012
29 January - 01 February 2012
Plenary Lectures and Symposia
[an error occurred while processing this directive]The scientific program will run for 3 full days from Monday, 29 January to Wednesday, 1 February 2012. There will be 4 Plenary Lectures and 13 Symposia (including the Presidential Symposium), featuring outstanding overseas and Australian speakers.
The Final Program Timetable can bedownloaded from here.
The Poster Program can be downloaded from here. Please note that late posters can be submitted until Monday, 12 December and these will be added to the program.
The full program, including plenary, symposium and oral presentation details can be downloaded from here.
Some abstracts will be selected for oral communication sessions, which will be held on the three full days of the conference.
The principal form of free communications will be posters. Posters will be on display for one day only. Poster sessions are scheduled during the afternoons of Monday, 30 January, Tuesday, 31 January and Wednesday, 1 February and will be grouped to provide opportunity for discussion across all scientific themes. The display space for posters will be 1.0 metre wide x 1.0 metre high. Velcro will be supplied - pins must not be used. Posterboards will be numbered.
Data projection will be available in all lecture rooms with presentations being accepted from DVD, CD or a USB Mass Storage Devices. We are providing Windows 7 running PowerPoint 2010 and Macintosh users will have access to a Macintosh notebook located at the lectern running PowerPoint and Keynote. We prefer that Macintosh files be transferred to the server and checked for faithful reproduction on the PC in the first instance. Should you have any questions prior to the meeting, please contact the AV Director, Mark Stevens by e-mail: firstname.lastname@example.org
ANS Plenary Lecture: Associate Professor Heather Young
Heather Young received her PhD from the University of Melbourne. She held post-doctoral positions with Professor David Vaney at the National Vision Research Institute and the University of Queensland, and then with Professor John Furness at the University of Melbourne. She is currently an Associate Professor and NHMRC Senior Research Fellow in the Department of Anatomy & Cell Biology at the University of Melbourne. Dr Young’s research area is the development of autonomic neurons, with a focus on the development of the enteric nervous system. She developed methods to image the migration of neural crest cells along the gut in order to study the etiology of Hirshsprung’s disease. Her current interests include examining the potential of cell-based therapies to treat Hirschsprung’s disease and other enteric neuropathies. Her contributions were recognized with the Janssen Award for Basic or Clinical Research in Digestive Sciences in 2002. Dr Young is an Associate Editor of Autonomic Neuroscience and she is on the editorial boards of four journals.
Overseas Plenary Lecture: Dr Feng Zhang (replacing Dr Karl Deisseroth)
Feng Zhang is an Assistant Professor in the MIT McGovern Institute, and a Core Faculty Member at the Broad Institute of MIT and Harvard. Born in China, he moved to the U.S. at the age of 11. He obtained a B.A. in Chemistry and Physics from Harvard and a PhD in Chemistry from Stanford. Before joining MIT he served as a Junior Fellow at the Harvard Society of Fellows. Feng has been a serial pioneer of disruptive technologies for neuroscience and molecular biology. While at Stanford, Feng pioneered a neuromodulation technology called optogenetics, which enables targeted control of distinct neural circuits in the brain of awake and behaving animals. Most recently, Feng developed transcription activator-like effectors (TALEs), a customizable DNA binding protein for targeted modulation and editing of mammalian genomes. He is deeply committed to the sharing of new technologies through the development of open source reagents and online resources..
Lawrie Austin Lecture: Professor Janusz Lipski
Professor Lipski obtained his MD degree and then a PhD in Physiology from the University of Warsaw, Poland. After his post-doctoral studies as a UNESCO/IBRO Fellow at the University of Gothenburg, Sweden, and then the University of Birmingham, UK, he was appointed as a Lecturer at the University of Warsaw. From 1983 to 1987, he worked as a Senior Research Fellow at the JCSMR in Canberra together with Prof. S. Redman. Subsequently he moved to Auckland, where he accepted a Chair in Neurophysiology. For over 20 years, his research interests focused on the brain mechanisms controlling the cardiovascular and respiratory systems in mammals. In recent years he moved into a new field: the mechanisms of neurodegeneration and neuroprotection in neurological disorders. The overall aim of this line of research is to characterize the mechanisms of neurodegeneration in stroke and Parkinson’s disease, and to develop new treatments based on improved knowledge of the properties of affected neurons. He has published 140 peer-reviewed original papers. In 1997, he received the Paxinos-Watson Prize from the ANS. In 2008, he was elected a Foreign Member of the Polish Academy of Sciences (PAU).
Eccles Lecture: Professor Marcus Stoodley
Professor Stoodley graduated with honours from medical school at the University of Queensland and went on to train in neurosurgery in Perth and Adelaide. After completing neurosurgery training in Australia, he completed further subspecialty training in vascular neurosurgery at Stanford University and the University of Chicago in the United States. On returning to Australia in 1999 he worked at the University of New South Wales and The Prince of Wales Hospital, where he established an area-wide vascular neurosurgery service and a neurosurgery research laboratory. In 2008 Professor Stoodley joined Macquarie University and moved his clinic and research laboratory to the Australian School of Advanced Medicine in 2010. Professor Stoodley has clinical expertise in neurovascular surgery, including aneurysm surgery, surgery for trigeminal neuralgia and hemifacial spasm, and bypass surgery for moyamoya disease and other vascular occlusive disorders. In addition, he has a special interest in Chiari malformation, syringomyelia, and spinal cord tumours. In 1997, Professor Stoodley was awarded a PhD for his research on the pathophysiology of syringomyelia. He directs the neurosurgery laboratory at the Australian School of Advanced Medicine and continues research on syringomyelia as well as developing new biological treatments for brain arteriovenous malformations (AVMs). He has produced more than 100 publications and has supervised over 15 research students.